1. Home
  2. CYTK vs SMTC Comparison

CYTK vs SMTC Comparison

Compare CYTK & SMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • SMTC
  • Stock Information
  • Founded
  • CYTK 1997
  • SMTC 1960
  • Country
  • CYTK United States
  • SMTC United States
  • Employees
  • CYTK N/A
  • SMTC N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • SMTC Semiconductors
  • Sector
  • CYTK Health Care
  • SMTC Technology
  • Exchange
  • CYTK Nasdaq
  • SMTC Nasdaq
  • Market Cap
  • CYTK 4.6B
  • SMTC 4.3B
  • IPO Year
  • CYTK 2004
  • SMTC N/A
  • Fundamental
  • Price
  • CYTK $49.76
  • SMTC $62.55
  • Analyst Decision
  • CYTK Buy
  • SMTC Strong Buy
  • Analyst Count
  • CYTK 15
  • SMTC 13
  • Target Price
  • CYTK $75.57
  • SMTC $60.54
  • AVG Volume (30 Days)
  • CYTK 2.7M
  • SMTC 2.0M
  • Earning Date
  • CYTK 11-05-2025
  • SMTC 08-25-2025
  • Dividend Yield
  • CYTK N/A
  • SMTC N/A
  • EPS Growth
  • CYTK N/A
  • SMTC N/A
  • EPS
  • CYTK N/A
  • SMTC 0.29
  • Revenue
  • CYTK $85,738,000.00
  • SMTC $996,476,000.00
  • Revenue This Year
  • CYTK $330.96
  • SMTC $15.91
  • Revenue Next Year
  • CYTK $73.41
  • SMTC $9.30
  • P/E Ratio
  • CYTK N/A
  • SMTC $217.27
  • Revenue Growth
  • CYTK 2635.74
  • SMTC 22.22
  • 52 Week Low
  • CYTK $29.31
  • SMTC $24.05
  • 52 Week High
  • CYTK $59.39
  • SMTC $79.52
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 63.01
  • SMTC 68.01
  • Support Level
  • CYTK $49.22
  • SMTC $59.71
  • Resistance Level
  • CYTK $53.58
  • SMTC $63.40
  • Average True Range (ATR)
  • CYTK 2.54
  • SMTC 2.23
  • MACD
  • CYTK 0.29
  • SMTC 0.20
  • Stochastic Oscillator
  • CYTK 76.53
  • SMTC 89.66

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About SMTC Semtech Corporation

Semtech Corp is engaged in designing, developing, manufacturing and marketing analog and mixed-signal semiconductors, algorithms and wireless semiconductors, connectivity modules, gateways, routers and connected services for IoT. The company operates in four reportable segments: Signal Integrity, Analog Mixed Signal and Wireless, IoT Systems and IoT Connected Services. The majority of the company's revenue is earned through Analog Mixed Signal and Wireless segment. Geographically majority of the company's revenue is earned from Asia Pacific region, company also operates in North America and Europe.

Share on Social Networks: